Medical tablet
Latest Merck Patent Gesellschaft mit beschraenkter Haftung Patents:
- 2-(HETEROCYCLYLBENZYL)PYRIDAZINONE DERIVATIVES
- 2-(heterocyclylbenzyl)pyridazinone derivatives
- 3 (3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives
- Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
- Particle beam process for the alignment of reactive mesogens
Description
FIG. 1 is a front elevational view of a medical tablet showing my new design;
FIG 2 is a side elevational view thereof, the opposite side elevational view being a mirror image of that shown;
FIG. 3 is a top plan view thereof;
FIG. 4 is a bottom plan view thereof;
FIG. 5 is a front perspective view thereof; and
FIG. 6 is a perspective view of the fractured medical tablet.
Referenced Cited
U.S. Patent Documents
| 21084 | September 1891 | Bayle |
| 56478 | October 1920 | Shores |
| D187372 | March 1960 | Dailey |
| D220956 | June 1971 | Roberts |
| D228456 | September 1973 | Ninger |
| 694745 | March 1902 | Hall |
| 2591328 | April 1952 | Yanik |
Patent History
Patent number: D299275
Type: Grant
Filed: Nov 26, 1986
Date of Patent: Jan 3, 1989
Assignee: Merck Patent Gesellschaft mit beschraenkter Haftung (Darmstadt)
Inventor: Wilhelm Ott (Dreieich)
Primary Examiner: Wallace R. Burke
Assistant Examiner: Kay H. Chin
Law Firm: Millen & White
Application Number: 6/935,669
Type: Grant
Filed: Nov 26, 1986
Date of Patent: Jan 3, 1989
Assignee: Merck Patent Gesellschaft mit beschraenkter Haftung (Darmstadt)
Inventor: Wilhelm Ott (Dreieich)
Primary Examiner: Wallace R. Burke
Assistant Examiner: Kay H. Chin
Law Firm: Millen & White
Application Number: 6/935,669
Classifications
Current U.S. Class:
D28/2;
Jeweled (D28/81)
